Clostridium difficile (C. diff) Nursing Care Plan

Nursing Diagnosis 1: Post Trauma Response

Diarrhea related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by ≥ 3 unformed stools in 24 hours (Bristol 6–7); Positive C. difficile toxin EIA or NAAT; Abdominal cramping and urgency; Recent broad-spectrum antibiotic exposure; Pseudomembranes on endoscopy or imaging when performed.

Interventions

• Document every stool: frequency, volume, consistency (Bristol scale), color, and presence of blood or mucus per facility documentation standard.
• Auscultate bowel sounds and assess the abdomen for distention, tenderness, and rigidity at intervals matched to clinical acuity and facility protocol.
• Monitor temperature at intervals matched to clinical acuity; report new fever or fever above ordered parameters.
• Review WBC, creatinine, lactate, and albumin as ordered and trend serial values.
• Inspect perianal skin each shift and after stooling episodes.
• Administer ordered antibiotic therapy (commonly oral vancomycin or fidaxomicin) on schedule per provider direction, pharmacy guidance, and facility protocol; confirm a reliable PO route.
• Do not administer antimotility agents (loperamide, diphenoxylate, anticholinergic agents) for CDI unless explicitly ordered by the provider team after risk/benefit review.
• Provide a skin-protective barrier (commonly zinc-based or dimethicone product) to the perianal area after stooling per facility skin-care protocol.
• Offer a bedside commode and place the call light within reach; respond promptly to urgency.
• Maintain IV access and administer ordered crystalloid and electrolyte replacement per provider direction and facility protocol.
• Educate the patient and family on completing the full ordered antibiotic course as directed by the provider, even when symptoms improve early.
• Teach the patient and family to perform hand hygiene with soap and water after every bathroom use, per facility infection-prevention policy.
• Reinforce provider recommendations regarding probiotic use rather than initiating probiotic therapy independently.
• Notify the provider for stool counts above ordered parameters, new bloody stool, abdominal distention or rigidity, or rising lactate.
• Coordinate GI consultation per provider direction when symptoms are not improving by the timeframe ordered by the provider team or when recurrence is suspected.

Outcome: Stool frequency and consistency are monitored and reported within ordered parameters; Bristol scale trend is documented through the ordered treatment course; Patient verbalizes understanding of the ordered antibiotic course and adherence plan.

Nursing Diagnosis 2: Fluid Volume Deficit

Fluid Volume Deficit related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by Multiple large-volume watery stools per 24 hours; Decreased oral intake due to nausea or anorexia; Dry mucous membranes, decreased skin turgor; Urine output below ordered parameters; Tachycardia, orthostatic blood-pressure changes.

Interventions

• Monitor heart rate, blood pressure (including orthostatics when ordered), and SpO₂ at intervals matched to clinical acuity and facility protocol.
• Maintain strict intake and output; calculate net 24-hour balance per facility protocol.
• Assess mucous membranes, skin turgor, and capillary refill each shift.
• Trend BUN/Cr, electrolytes, and lactate as ordered.
• Weigh the patient daily on the same scale, same garments, same time when clinical status allows.
• Administer ordered IV crystalloid (commonly NS or LR) per provider direction; monitor urine output, mean arterial pressure, and hemodynamic indicators per facility protocol.
• Administer ordered electrolyte replacement (commonly K⁺ and Mg²⁺) per facility electrolyte-replacement protocol when values are below threshold.
• Offer ordered oral fluids or oral rehydration solution at small, frequent intervals when nausea allows and an oral intake order is in place.
• Administer ordered antiemetics to support oral intake.
• Educate the patient on rehydration with ordered oral rehydration solutions or broth rather than plain water alone when the provider supports oral intake.
• Teach the patient signs of dehydration to report at home: dizziness on standing, dark urine, decreased urine frequency, dry mouth.
• Notify the provider for urine output, heart rate, or blood pressure outside ordered parameters or for new mental-status changes.
• Escalate per facility rapid-response criteria for hypotension that does not respond to ordered fluid resuscitation or for rising lactate.

Outcome: Urine output is monitored and reported within ordered parameters; Heart rate and blood pressure are monitored and reported within ordered parameters; Mucous membranes and skin turgor are assessed and changes are reported.

Nursing Diagnosis 3: Skin Integrity Impairment (perianal)

Skin Integrity Impairment (perianal) related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by Multiple unformed stools per 24 hours; Moisture-associated perianal erythema or denudation; Patient report of perianal burning or stinging; Decreased mobility or self-care limiting timely cleansing; Concurrent fecal incontinence in older or debilitated adults.

Interventions

• Inspect perianal and surrounding skin each shift and after stooling episodes; document findings per facility skin-assessment standard.
• Assess for perianal pain, burning, or itching using a 0–10 scale or facility-approved comfort tool when the patient is able to report.
• Identify mobility and self-care limitations that may delay cleansing after stooling.
• Cleanse the perianal area with a no-rinse perineal cleanser or soft, pH-balanced wipes after each stool per facility skin-care protocol; avoid vigorous scrubbing.
• Apply ordered skin-protective barrier (commonly zinc-based or dimethicone) after cleansing per facility protocol.
• Consider a moisture-wicking pad system per facility protocol when appropriate.
• Coordinate with the wound or skin-care nurse per facility consult criteria when breakdown is present or progressing.
• When the patient is able, teach skin-care steps, including gentle cleansing and barrier-product reapplication after each stool.
• Educate the family on cleansing technique, barrier-product use, and the importance of avoiding alcohol-based skin products on broken skin.
• Notify the provider for open lesions, increasing redness or pain, new bleeding from the perianal area, or signs that may suggest infection (warmth, purulence).
• Coordinate with the provider team and pharmacy if the patient is on a medication regimen that may delay healing (e.g., chronic steroids).

Outcome: Perianal skin is assessed each shift and findings are documented per facility protocol; Skin barrier products are applied as ordered and per facility skin-care protocol; Patient verbalizes a comfort improvement or reports decreased perianal pain when able.

Nursing Diagnosis 4: Infection Risk (Transmission)

Infection Risk (Transmission) related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by Confirmed CDI (positive toxin EIA or NAAT); Active diarrhea with high spore burden; Shared bathroom or roommate environment; Spore-forming organism not reliably killed by alcohol-based sanitizers; Multiple staff and visitor contacts per day.

Interventions

• Verify isolation signage, PPE supplies, and dedicated equipment are in place each shift per facility infection-prevention policy.
• Monitor stool pattern and track time since the last unformed stool per facility documentation standard.
• Observe staff, family, and patient hand-hygiene technique each shift per facility audit practice.
• Implement CONTACT precautions (gown and gloves on entry, dedicated room when possible, dedicated equipment) per facility infection-prevention policy for the duration determined by infection prevention.
• Perform hand hygiene with soap and water before and after patient contact per facility infection-prevention policy; reinforce this practice with the team rather than relying on alcohol-based sanitizer.
• Coordinate with infection prevention and bed management on room placement (commonly a private room or a CDI cohort) and a dedicated toilet or commode per facility policy.
• Coordinate with environmental services for daily cleaning with a sporicidal agent (commonly bleach-based) per facility infection-prevention policy.
• Dedicate equipment (stethoscope, BP cuff, thermometer) to the patient and disinfect with the facility-designated sporicidal product between uses.
• Educate the family on PPE donning and doffing and on soap-and-water hand hygiene before leaving the room per facility policy.
• Teach the patient to use the assigned toilet or commode and to notify staff before leaving the room per facility infection-prevention policy.
• Educate the patient and household on home cleaning of high-touch surfaces with a diluted bleach solution after discharge per facility discharge education.
• Notify infection prevention for any suspected secondary case or precaution breach per facility infection-prevention policy.
• Coordinate antibiotic stewardship review with the provider team and pharmacy to narrow, shorten, or discontinue unnecessary antibiotics per facility stewardship protocol.
• Coordinate documentation of precaution discontinuation criteria with infection prevention per facility policy.

Outcome: CONTACT precautions are implemented and maintained per facility infection-prevention policy; Soap-and-water hand hygiene is observed for patient, family, and staff per facility policy; Environmental cleaning with a sporicidal agent is documented per facility protocol.

Nursing Diagnosis 5: Acute Pain

Acute Pain related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by Patient reports cramping abdominal pain; Guarding with palpation of the lower abdomen; Facial grimacing with stooling episodes; Restlessness or inability to find a comfortable position; Diaphoresis and tachycardia during pain peaks.

Interventions

• Assess pain intensity, location, character, and timing using the facility-approved tool at intervals matched to clinical acuity and PRN.
• Differentiate cramping or colicky pain from constant severe pain or rebound tenderness; report changes to the provider team.
• Monitor vital signs during pain peaks; document tachycardia or diaphoresis when present.
• Administer ordered analgesics per provider direction, pharmacy guidance, and facility protocol.
• Coordinate with the provider team to limit opioid use when possible; reinforce non-opioid and non-pharmacologic options per provider direction.
• Coordinate with the provider team to avoid antimotility and anticholinergic agents for diarrhea or pain unless explicitly ordered after risk/benefit review.
• Apply a warm pack to the abdomen during cramping when ordered or supported by facility protocol.
• Position the patient for comfort (side-lying with knees flexed when tolerated) and cluster cares around peak pain windows when feasible.
• Provide a calm environment with dimmed lights and limited stimuli at night per facility sleep-hygiene practice.
• Teach diaphragmatic breathing and guided imagery the patient can use during cramping episodes.
• Educate the patient to report new severe pain, sudden relief, or worsening distention promptly.
• Notify the provider for pain unrelieved by ordered analgesics, new rebound tenderness, or rigidity.
• Coordinate with the prescriber on opioid-sparing analgesic strategies when feasible per facility analgesia protocol.

Outcome: Pain is assessed and reassessed per facility pain-management standard; Patient verbalizes acceptable pain control on the facility-approved scale; Patient demonstrates at least one non-pharmacologic comfort strategy when appropriate.

Nursing Diagnosis 6: Knowledge Deficit

Knowledge Deficit related to Clostridioides difficile infection (CDI): toxin-mediated colitis ranging from mild diarrhea to fulminant colitis with toxic megacolon as evidenced by First episode of CDI for the patient or family; Recent broad-spectrum antibiotic exposure with limited understanding of the connection; Unfamiliarity with CONTACT precautions and soap-and-water hand hygiene; Multiple medication and follow-up steps in the discharge plan; Anxiety about recurrence (widely reported 20–30% after the first episode).

Interventions

• Assess baseline understanding of CDI, recent antibiotic exposure, hand hygiene, and the discharge plan using teach-back per facility education standard.
• Identify learning barriers (language, literacy, cognition, sensory, cultural) and coordinate interpreter or accessibility resources per facility policy.
• Identify the household decision-maker and primary caregiver, especially for older or debilitated adults.
• Provide facility-approved CDI education materials in the patient’s preferred language and reading level per facility patient-education protocol.
• Coordinate medication education with pharmacy on the ordered antibiotic course and follow-up steps per facility protocol.
• Reinforce that soap and water are used for hand hygiene at home per facility infection-prevention discharge education, rather than alcohol-based sanitizer alone.
• Teach the patient and family what CDI is, that it is often related to antibiotic exposure, and why the team has implemented the current plan, using plain language.
• Teach the importance of completing the full ordered antibiotic course as directed by the provider, even when symptoms improve.
• Teach warning signs that should prompt contact with the provider or return to care: fever, worsening pain or distention, blood in stool, dehydration symptoms, or return of diarrhea after improvement.
• Teach household cleaning with a diluted bleach solution for high-touch surfaces after discharge per facility discharge education.
• Educate the patient and family on the recurrence rate (commonly cited as 20–30% after the first episode) and the plan to discuss further options (e.g., fidaxomicin, bezlotoxumab, fecal microbiota therapy) with the provider team if recurrence occurs.
• Coordinate discharge planning with case management, pharmacy, and the provider team per facility protocol.
• Notify the provider when patient understanding remains incomplete after structured teach-back and reinforcement.

Outcome: Patient and family verbalize what CDI is, why precautions are in place, and how the ordered antibiotics work; Patient verbalizes the importance of completing the full ordered antibiotic course; Patient and family demonstrate soap-and-water hand hygiene.

Clostridioides difficile is a gram-positive, anaerobic, spore-forming bacillus. Pathogenesis often begins with antibiotic exposure disrupting the protective gut microbiome, allowing C. difficile overgrowth and elaboration of toxin A (enterotoxin) and toxin B (cytotoxin, the more virulent of the two). Toxin damage to colonic epithelium produces inflammation, pseudomembrane formation, and watery diarrhea. The hypervirulent BI/NAP1/027 strain produces increased toxin plus a binary toxin and has been associated with worse outcomes. Risk factors include recent antibiotic exposure (fluoroquinolones, clindamycin, and cephalosporins carry higher risk), age > 65, hospitalization, proton-pump inhibitor use (weak association), tube feeding, and inflammatory bowel disease. Severity classification per 2021 ACG and 2017 IDSA/SHEA guidance: mild-moderate (WBC < 15 K, Cr < 1.5 × baseline), severe (WBC ≥ 15 K or Cr ≥ 1.5 × baseline), and fulminant (formerly “severe-complicated”; described by hypotension, ileus, or toxic megacolon). Because the organism is spore-forming, alcohol-based hand sanitizer does not reliably kill the spores — soap and water are used for hand hygiene per facility infection-prevention policy. Recurrence rates of 20–30% after the first episode are widely reported and may rise with each subsequent recurrence.

• Hand hygiene: Soap & water per facility policy (alcohol gel does not kill spores)
• Testing algorithm: 2-step (commonly): GDH + toxin EIA with NAAT as tiebreaker per lab protocol
• Severity marker: WBC ≥ 15 K or Cr ≥ 1.5 × baseline (per ACG/IDSA)
• First-line PO vanco: Commonly 125 mg PO QID × 10 days (per IDSA 2021)
• Recurrence rate: 20–30% after the first episode (widely reported)

• Makic, M. B. F., & Martinez-Kratz, M. R. (Eds.). (2023). Ackley and Ladwig’s Nursing Diagnosis Handbook: An Evidence-Based Guide to Planning Care (13th ed.). Elsevier.
• Kelly, C. R., Fischer, M., Allegretti, J. R., et al. (2021). ACG Clinical Guidelines: Prevention, Diagnosis, and Treatment of Clostridioides difficile Infections. American Journal of Gastroenterology, 116(6), 1124–1147.
• McDonald, L. C., Gerding, D. N., Johnson, S., et al. (2018). Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the IDSA and SHEA. Clinical Infectious Diseases, 66(7), e1–e48.
• Johnson, S., Lavergne, V., Skinner, A. M., et al. (2021). Clinical Practice Guideline by the IDSA and SHEA: 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults. Clinical Infectious Diseases, 73(5), e1029–e1044.